BAX

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Baxter International Inc.

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
CEO
Jose Almeida
Employees
2021
Headquarters

1 Baxter Pkwy
Deerfield, Illinois 60015-4625
Phone: 18479482000
www.baxter.com

News

Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Jun 06, 2024 20:15pm

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Goldman Sachs sets Baxter stock at neutral
May 30, 2024 09:16am

https://www.investing.com/news/company-news/goldman-sachs-sets-baxter-stock-at-neutral-93CH-3462582


Source:Investing.com
New Cohort Study Data Shows Baxter''s Expanded Hemodialysis Known as HDx Therapy Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
May 29, 2024 12:56pm

https://www.investing.com/news/press-releases/new-cohort-study-data-shows-baxters-expanded-hemodialysis--known-as-hdx-therapy--is-associated-with-approximately-25-lower-mortality-rate-for-up-to-four-years-93CH-3461031


Source:Investing.com
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
May 29, 2024 12:45pm

Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, “Survival of expanded hemodialysis and Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Baxter to Present at Jefferies 2024 Global Healthcare Conference
May 23, 2024 20:15pm

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024. Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Bolton v Oxford United: League One play-off final – live
May 18, 2024 14:26pm

Updates from the 4.15pm BST kick-off at Wembley Have any thoughts? Send them to Will via email This is what they are playing for … Baxter, Dacres-Cogley, Jones, Almeida Santos, Toal, Ogbeta, Sheehan, Thomason, Maghoma, Collins, Charles Continue reading…


Source:The Guardian
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
May 15, 2024 18:00pm

Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240515943576/en/ Baxter announced the mission and logo for its proposed kidney care and acute therapies Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Baxter''s Clinolipid gets FDA approval for use in infants
May 13, 2024 16:23pm

No summary available.


Source:Seeking Alpha
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
May 13, 2024 12:45pm

Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Baxter downgraded to hold by TD Cowen in wake of selloff
May 10, 2024 16:39pm

No summary available.


Source:Seeking Alpha